Triple-negative breast cancers (TNBCs), defined by lack of expression of estrogen receptor, progesterone receptor and HER2, account for 12–17% of breast cancers and are clinically perceived as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback